The trial outcomes for ENV-101 demonstrated statistically significant improvements in lung function and lung capacity.

Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, ...